Karen Sims
Chief Tech/Sci/R&D Officer chez ARBUTUS BIOPHARMA CORPORATION
Fortune : 323 898 $ au 31/03/2024
Profil
Karen Sims is currently the Chief Medical Officer at Arbutus Biopharma Corp.
She started this position in 2023 and is still currently employed there.
In terms of education, Dr. Sims holds a doctorate degree from the University of Pennsylvania and another doctorate degree from the University of Pennsylvania Medical Center.
She also has an undergraduate degree from Bates College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 02/02/2024 | 125 542 ( 0,07% ) | 323 898 $ | 31/03/2024 |
Postes actifs de Karen Sims
| Sociétés | Poste | Début |
|---|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Chief Tech/Sci/R&D Officer | 10/07/2023 |
Formation de Karen Sims
| University of Pennsylvania | Doctorate Degree |
| Bates College | Undergraduate Degree |
| University of Pennsylvania Medical Center | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Health Technology |
